SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001123292-24-000398
Filing Date
2024-12-19
Accepted
2024-12-19 16:43:27
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D/A  
1 primary_doc.xml SCHEDULE 13D/A 9937
  Complete submission text file 0001123292-24-000398.txt   11635
Mailing Address CLARENCE THOMAS BUILDING P.O. BOX 4649, ROAD TOWN TORTOLA D8 VG1110
Business Address CLARENCE THOMAS BUILDING P.O. BOX 4649, ROAD TOWN TORTOLA D8 VG1110 416-737-7600
PORTAGE BIOTECH INC. (Subject) CIK: 0001095435 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 0331
Type: SCHEDULE 13D/A | Act: 34 | File No.: 005-81765 | Film No.: 241563930
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address VIKING HOUSE NELSON STREET DOUGLAS Y8 IM1 2AH
Business Address
Mellon James (Filed by) CIK: 0001727650 (see all company filings)

Type: SCHEDULE 13D/A